À PROPOS DE CET ÉPISODE
Part 1 has landed!
Join in on their conversation on the Cell and Gene Therapy industry.
Some topics that Darwin and Rajiv discuss in this episode are:
- The current status of cell and gene therapy approvals,
- CMC challenges
- AAV-based gene therapy
Stay tuned to part 2 of their conversation. Remember to subscribe to the podcast to get the latest releases
Rajiv Gangurde LinkedIn profile: https://www.linkedin.com/in/rajiv-gangurde-ph-d-5b8ab5a/
Anglais
États-Unis
TRANSCRIPTION 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
RECHERCHER LES ÉPISODES PASSÉS
Rechercher les épisodes précédents de SSI Executive Conversations.
AUTRES ÉPISODES DANS CE PODCAST
First episode of 2025 proves to be a great one with Zack Lyon. Listen in.
Our next guest on the SSI Executive Conversation Podcast is Jennifer Fried, CEO and Co-founder of Flow Medical, a surgical software platform for treating pulmonary embolisms.
Some topics that Darwin and Jennifer discuss are:
- How Flow Medical started
- Why the technology is so significant
- Challe…
Part 3 is Here! Join Darwin and Aaron Snyder, VP of Quality at Allotex, as they wrap up with a powerful discussion on career growth, the critical role of career ladders, and how they drive higher retention, stability, and reduced risk in organizations.
Aaron Snyder LinkedIn: https://www.linkedin.…
Just released, Part 2 of Darwin and Rajiv's discussion on Cell and Gene Therapy.
Some topics they discuss are:
- Clinical holds
- Gene Therapy developers and outsourcing
- Evolving regulatory guidance for C>.
Rajiv Gangurde LinkedIn: https://www.linkedin.com/in/rajiv-gangurde-ph-d-5b8ab5a/
#bi…
Avertissement: Le podcast et les illustrations intégrés sur cette page proviennent de Darwin Shurig, qui est la propriété de son propriétaire et n'est ni affilié ni approuvé par Listen Notes, Inc.
MODIFIER
Merci de nous avoir aidé à tenir la base de données de podcasts à jour.
